Our year in review

Neuroblastoma Australia's 2018-2019 Annual Report provides a summary of what we achieved, the impact we've made and how we worked towards our mission to find safer and more effective treatments for the devastating childhood cancer neuroblastoma.

Thanks to the dedication of our supporters we will have invested over $2.1 million in research by 2020 however, we continue to be a small charity, mindful of costs but focused on developing further to reach our goal – better, safer, kinder treatments for neuroblastoma.

Read the latest report Neuroblastoma Australia 2018-2019 Annual Report Cover

Financials

Neuroblastoma Australia was a volunteer charity until 2016 donating 100% of proceeds to research. In 2016 the charity took on the challenge of growing and developing with the ambition of raising more funds. The charity employed people for the first time and has invested in improving overall resources and skills to be able to achieve its mission more effectively.

The charity’s main costs are the event costs which however provide the bulk of fundraising. Please refer to our audited Financial Reports below.

We are delighted to have the services of Moore Stephens accountants to support our finance operations.

More information